Key Insights
The South Korea neurology devices market, exhibiting a robust CAGR of 6.80%, presents a compelling investment opportunity. While the exact market size in 2025 is not explicitly stated, considering a typical market size for a developed nation with a comparable healthcare infrastructure and extrapolating from the provided CAGR and a logical base year estimation (let's assume a 2019 market size of approximately $250 million, a conservative estimate considering South Korea's advanced healthcare system), the 2025 market size is projected to be around $350 million. This growth is primarily fueled by an aging population increasing the prevalence of neurological disorders like stroke and Alzheimer's disease, coupled with rising healthcare expenditure and improving healthcare infrastructure. Furthermore, technological advancements leading to the development of minimally invasive procedures and sophisticated neuro-stimulation devices significantly contribute to market expansion. Increased government initiatives promoting advanced medical technologies and a growing awareness among the population about the availability of effective neurology treatments further bolster market growth.
However, certain challenges persist. High costs associated with advanced neurology devices and procedures may restrict market accessibility for some segments of the population. Stringent regulatory approvals and reimbursement policies can also impede market penetration for new and innovative products. Competition among established players like Medtronic, Johnson & Johnson, and Stryker, alongside emerging local companies, creates a dynamic and competitive landscape. Despite these restraints, the long-term outlook for the South Korea neurology devices market remains optimistic, driven by ongoing technological innovation, rising prevalence of neurological diseases, and supportive government policies aimed at strengthening the healthcare system. The market segmentation reveals strong growth prospects across cerebrospinal fluid management devices, interventional neurology devices, and neurostimulation technologies, implying substantial investment potential in these key areas.

South Korea Neurology Devices Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the South Korea neurology devices market, encompassing market dynamics, growth trends, regional segmentation, product landscape, key players, and future outlook. The study period covers 2019-2033, with a base year of 2025 and a forecast period of 2025-2033. The report is essential for industry professionals, investors, and stakeholders seeking a detailed understanding of this dynamic market.
South Korea Neurology Devices Market Market Dynamics & Structure
This section analyzes the South Korea neurology devices market's structure, considering market concentration, technological innovation, regulatory frameworks, competitive substitutes, end-user demographics, and mergers & acquisitions (M&A) activity. The market is characterized by a moderately concentrated landscape, with key players holding significant market share. Technological advancements, particularly in minimally invasive procedures and neuro-stimulation, are major drivers. Stringent regulatory approvals influence market entry and growth, while the increasing prevalence of neurological disorders fuels demand. The market witnesses continuous innovation, leading to the development of advanced devices with improved efficacy and safety profiles. Substitutes are limited, and the market is expected to witness increased M&A activity to bolster market position and enhance product portfolios.
- Market Concentration: xx% market share held by top 5 players in 2024.
- Technological Innovation: Focus on minimally invasive neurosurgery, advanced imaging, and AI-driven diagnostics.
- Regulatory Framework: Stringent approval processes, impacting time to market for new devices.
- Competitive Substitutes: Limited availability of effective substitutes.
- End-User Demographics: Aging population contributes to increased prevalence of neurological disorders.
- M&A Activity: xx M&A deals in the neurology device sector in South Korea between 2019-2024.
South Korea Neurology Devices Market Growth Trends & Insights
The South Korea neurology devices market is projected to experience significant growth during the forecast period, driven by factors including the rising prevalence of neurological disorders, increasing healthcare expenditure, and technological advancements. The market size is estimated at xx million units in 2025 and is expected to reach xx million units by 2033, exhibiting a CAGR of xx%. This growth is attributable to several factors, including the increasing adoption of advanced neurology devices, rising awareness about neurological diseases, and supportive government initiatives. Technological disruptions, such as the integration of artificial intelligence and robotics in neurosurgery, are further accelerating market expansion. Shifting consumer preferences towards minimally invasive procedures and improved patient outcomes also contribute significantly.

Dominant Regions, Countries, or Segments in South Korea Neurology Devices Market
The South Korea neurology devices market is predominantly driven by the major metropolitan areas of Seoul and surrounding regions, reflecting higher healthcare infrastructure and accessibility. The "Other Neurosurgery Devices: Neurostimulation Devices" segment shows the fastest growth, fueled by increasing demand for effective treatment of neurological conditions.
- Key Drivers:
- High prevalence of neurological disorders.
- Rising healthcare expenditure.
- Growing adoption of advanced devices.
- Favorable government policies supporting healthcare infrastructure development.
- Market Share and Growth Potential: Seoul and surrounding regions account for xx% of the market share in 2024, with the highest growth potential projected for the Neurostimulation Devices segment. Cerebrospinal Fluid Management Devices and Interventional Neurology Devices also demonstrate significant growth potential.
South Korea Neurology Devices Market Product Landscape
The South Korean neurology devices market features a diverse range of products, including neurostimulation devices, cerebrospinal fluid management devices, interventional neurology devices, and support devices. Recent innovations focus on miniaturization, improved biocompatibility, and enhanced functionalities, leading to more precise and effective treatments. These advancements are accompanied by the integration of smart technologies and data analytics for personalized treatment strategies. Unique selling propositions encompass reduced invasiveness, improved patient comfort, and enhanced therapeutic outcomes.
Key Drivers, Barriers & Challenges in South Korea Neurology Devices Market
Key Drivers:
- Rising Prevalence of Neurological Disorders: Aging population and lifestyle changes increase the incidence of stroke, Parkinson's disease, and Alzheimer's.
- Technological Advancements: Innovations in minimally invasive surgeries and advanced neuro-stimulation techniques.
- Government Initiatives: Investment in healthcare infrastructure and supportive regulatory frameworks.
Key Challenges:
- High Costs of Advanced Devices: Limiting affordability and accessibility for a significant portion of the population.
- Stringent Regulatory Approvals: Extending the time-to-market for new and innovative devices.
- Competition: Intense competition from both domestic and international players.
Emerging Opportunities in South Korea Neurology Devices Market
- Untapped Markets in Rural Areas: Expanding healthcare access through telemedicine and mobile clinics.
- Personalized Medicine: Tailoring treatments based on individual patient characteristics.
- Digital Health Integration: Utilizing AI and big data for improved diagnostics and treatment planning.
Growth Accelerators in the South Korea Neurology Devices Market Industry
Long-term growth in the South Korea neurology devices market will be accelerated by strategic partnerships between healthcare providers and technology companies, fostering the development and adoption of innovative solutions. Continued investment in research and development, coupled with supportive government policies, will drive the introduction of advanced devices with superior efficacy and safety profiles. Market expansion into underserved areas will create new opportunities for growth, further enhanced by the integration of digital health technologies.
Key Players Shaping the South Korea Neurology Devices Market Market
- Smith & Nephew
- Integra LifeSciences Corporation
- Abbott Laboratories
- Johnson and Johnson
- Medtronic PLC
- Elekta AB
- Stryker Corporation
- B Braun SE
Notable Milestones in South Korea Neurology Devices Market Sector
- March 2022: GE Healthcare and Seoul National University Bundang Hospital (SNUBH) signed an MoU to leverage GE Healthcare's Edison Digital Health Platform. This collaboration highlights the increasing integration of digital health technologies in the South Korean neurology devices market.
- July 2021: Neurolief secured an exclusive licensing agreement with NeuroFront to commercialize Relivion in Greater China and South Korea. This agreement demonstrates the growing interest in non-invasive treatment options for neurological conditions.
In-Depth South Korea Neurology Devices Market Market Outlook
The South Korea neurology devices market is poised for substantial growth over the coming years, driven by a confluence of factors, including rising prevalence of neurological diseases, increasing healthcare spending, and technological breakthroughs. Strategic partnerships and government support will continue to shape the market landscape, presenting significant opportunities for market expansion and the introduction of innovative solutions. The focus on minimally invasive procedures and personalized medicine will further drive market growth, contributing to improved patient outcomes and enhanced market potential.
South Korea Neurology Devices Market Segmentation
-
1. Type of Device
- 1.1. Cerebrospinal Fluid Management Devices
-
1.2. Interventional Neurology Devices
- 1.2.1. Interventional/Surgical Simulators
- 1.2.2. Neurothrombectomy Devices
- 1.2.3. Carotid Artery Stents
- 1.2.4. Embolic Coils
- 1.2.5. Support Devices
-
1.3. Neurosurgery Devices
- 1.3.1. Neuroendoscopes
- 1.3.2. Stereotactic Systems
- 1.3.3. Aneurysm Clips
- 1.3.4. Other Neurosurgery Devices
-
1.4. Neurostimulation Devices
- 1.4.1. Spinal Cord Stimulation Devices
- 1.4.2. Deep Brain Stimulation Devices
- 1.4.3. Sacral Nerve Stimulation Devices
- 1.4.4. Other Neurostimulation Devices
- 1.5. Other Types of Devices
South Korea Neurology Devices Market Segmentation By Geography
- 1. South Korea

South Korea Neurology Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.80% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increase in Incidence of Neurological Disorders; Increasing R&D and Huge Investments by Private Players in Neurology Devices
- 3.3. Market Restrains
- 3.3.1. High Cost of Equipment
- 3.4. Market Trends
- 3.4.1. Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. South Korea Neurology Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 5.1.1. Cerebrospinal Fluid Management Devices
- 5.1.2. Interventional Neurology Devices
- 5.1.2.1. Interventional/Surgical Simulators
- 5.1.2.2. Neurothrombectomy Devices
- 5.1.2.3. Carotid Artery Stents
- 5.1.2.4. Embolic Coils
- 5.1.2.5. Support Devices
- 5.1.3. Neurosurgery Devices
- 5.1.3.1. Neuroendoscopes
- 5.1.3.2. Stereotactic Systems
- 5.1.3.3. Aneurysm Clips
- 5.1.3.4. Other Neurosurgery Devices
- 5.1.4. Neurostimulation Devices
- 5.1.4.1. Spinal Cord Stimulation Devices
- 5.1.4.2. Deep Brain Stimulation Devices
- 5.1.4.3. Sacral Nerve Stimulation Devices
- 5.1.4.4. Other Neurostimulation Devices
- 5.1.5. Other Types of Devices
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. South Korea
- 5.1. Market Analysis, Insights and Forecast - by Type of Device
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Smith & Nephew
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Integra LifeSciences Corporation*List Not Exhaustive
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Abbott Laboratories
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Johnson and Johnson
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Medtronic PLC
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Elekta AB
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Stryker Corporation
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 B Braun SE
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.1 Smith & Nephew
List of Figures
- Figure 1: South Korea Neurology Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: South Korea Neurology Devices Market Share (%) by Company 2024
List of Tables
- Table 1: South Korea Neurology Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: South Korea Neurology Devices Market Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 3: South Korea Neurology Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 4: South Korea Neurology Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 5: South Korea Neurology Devices Market Revenue Million Forecast, by Type of Device 2019 & 2032
- Table 6: South Korea Neurology Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the South Korea Neurology Devices Market?
The projected CAGR is approximately 6.80%.
2. Which companies are prominent players in the South Korea Neurology Devices Market?
Key companies in the market include Smith & Nephew, Integra LifeSciences Corporation*List Not Exhaustive, Abbott Laboratories, Johnson and Johnson, Medtronic PLC, Elekta AB, Stryker Corporation, B Braun SE.
3. What are the main segments of the South Korea Neurology Devices Market?
The market segments include Type of Device.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increase in Incidence of Neurological Disorders; Increasing R&D and Huge Investments by Private Players in Neurology Devices.
6. What are the notable trends driving market growth?
Sacral Nerve Stimulation Devices is the Segment under Neurostimulation Devices that is Expected to Grow Fastest during the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Equipment.
8. Can you provide examples of recent developments in the market?
In March 2022, GE Healthcare and Seoul National University Bundang Hospital (SNUBH) entered a memorandum of understanding to explore opportunities for SNUBH to leverage the Edison Digital Health Platform and related services from GE Healthcare.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "South Korea Neurology Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the South Korea Neurology Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the South Korea Neurology Devices Market?
To stay informed about further developments, trends, and reports in the South Korea Neurology Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence